PerpEquities

AstraZeneca PLC (AZN) balance sheet

NYSE · Healthcare · Drug Manufacturers - General · 96,100 employees · CEO Pascal Claude Roland Soriot

Price
$186.65 +7.02%
Market cap
$289B
Enterprise value
$316B
Last report
Q3 '26 filed 2026-10-30
Next report
2027-02-09 EPS est. $2.41

At the end of Q3 '26 AstraZeneca PLC (AZN) held $8.15B in cash and short-term investments against $34.1B of debt incl. leases. Total assets $120B, total liabilities $68B, shareholders' equity $51.6B.

Balance sheet

Balance sheetTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Assets
Cash & equivalents$5.84B$7.84B$6.92B$4.8B$5.49B$5.23B$7.06B$8.14B$5.71B$7.56B$4.89B$7.92B
Short-term investments$20M$180M$160M$133M$166M$165M$50M$39M$30M$115M$74.9M$230M
Receivables$10.5B$11.1B$11B$11.9B$13B$13.3B$14.2B$14.3B$15.2B$14.1B$16B$16.4B
Inventory$5.42B$5.34B$5.67B$5.66B$5.29B$5.88B$6.47B$6.59B$6.56B$6.57B$6.92B$6.87B
Other current assets$1.64B$1.16B$1.6B$1.68B$1.91B$1.61B$1.2B$827M$1.25B$1.26B$75.9M$20M
Current assets$25.1B$25.6B$25.4B$24.2B$25.8B$26.1B$28.9B$29.9B$28.7B$29.6B$27.9B$31.4B
Property, plant & equipment (net)$10.5B$10.6B$10.8B$11.5B$11.6B$12.3B$13.2B$13.8B$14.7B$14.9B$16.3B$16.7B
Long-term investments$0$0$0$2.01B$1.73B$1.9B$4.85B$2.29B$2.53B$4.24B$4.66B$4.67B
Goodwill$20B$20B$21.1B$21.1B$21B$21.1B$21.2B$21.2B$21.2B$21.2B$21.2B$21.1B
Intangible assets$38.1B$38.8B$39.4B$39.4B$37.2B$37.6B$37.9B$38.2B$37.8B$36.9B$37.7B$38.1B
Deferred tax assets$4.72B$4.62B$4.73B$5.34B$5.35B$6.1B$6.26B$0$5.83B$5.59B$6.48B$6.64B
Other non-current assets$2.71B$2.65B$2.89B$1.37B$1.28B$1.14B$0$9.04B$3.21B$1.52B$1.51B$1.06B
Non-current assets$76.1B$76.7B$78.9B$80.8B$78.2B$80.1B$83.5B$84.5B$85.4B$84.4B$87.8B$88.3B
Total assets$101B$102B$104B$105B$104B$106B$112B$114B$114B$114B$116B$120B
Liabilities
Accounts payable$3.27B$19.7B$20.5B$21.7B$22.5B$22.5B$24B$25B$25.3B$22.5B$22.9B$23.5B
Short-term debt$5.13B$6.05B$5.07B$1.25B$2.16B$3.43B$6.49B$6.2B$3.19B$7.58B$6.23B$5.38B
Taxes payable$2.08B$1.63B$1.53B$1.47B$1.41B$0$1.43B$0$0$1.3B$0$0
Other current liabilities$17.5B$1.24B$1.22B$1.2B$1.5B$2.81B$1.27B$1.18B$686M$807M$957M$679M
Current liabilities$30.5B$28.9B$28.6B$25.9B$27.9B$29.1B$33.5B$34.1B$30.6B$32.6B$31.5B$31.2B
Long-term debt$22.4B$27.3B$27.2B$28.9B$26.5B$26.7B$24.7B$24.7B$24.7B$24.5B$23.7B$26.4B
Lease obligations (non-current)$857M$961M$949M$1.11B$1.11B$1.2B$1.27B$1.38B$1.42B$1.51B$2.32B$2.33B
Deferred revenue (non-current)$7M$0$0$0$0$0$0$0$0$0$0$0
Deferred tax liabilities$2.84B$2.62B$3.33B$3.57B$3.31B$0$3.62B$3.6B$3.5B$3.47B$3.46B$3.61B
Other non-current liabilities$5.34B$5.05B$4.67B$4.63B$4.37B$8.06B$4.48B$4.75B$5.1B$4.63B$4.44B$4.42B
Non-current liabilities$31.4B$35.9B$36.2B$38.2B$35.3B$36B$34.1B$34.4B$34.7B$34.1B$33.9B$36.8B
Total liabilities$62B$64.8B$64.7B$64.1B$63.2B$65.1B$67.6B$68.5B$65.4B$66.6B$65.4B$68B
Equity
Common stock & paid-in capital$388M$388M$388M$388M$388M$388M$388M$388M$388M$388M$388M$387M
Retained earnings$1.5B-$212M$1.85B$3.14B$3.16B$3.36B$7.02B$8.21B$11B$9.67B$12.6B$14B
Accumulated other comprehensive income$0$0$0$1.99B$0$2.05B$2.07B$2.04B$0$0$2.03B$1.98B
Shareholders' equity$39.1B$37.4B$39.5B$40.7B$40.8B$41B$44.7B$45.9B$48.7B$47.3B$50.2B$51.6B
Debt
Total debt (incl. leases)$28.6B$34.6B$33.5B$31.6B$30.1B$31.7B$32.8B$32.7B$29.7B$33.9B$32.2B$34.1B
Net debt (debt - cash)$22.8B$26.7B$26.6B$26.8B$24.6B$26.5B$25.8B$24.5B$24B$26.4B$27.3B$26.2B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates: Financial Modeling Prep.

Data as of 2026-11-01